The Children’s Mercy Kansas City Division of Hematology/Oncology/Blood and Marrow Transplant is a national leader in cancer treatment. The program provides pediatric patients with comprehensive clinical services and innovative treatment (including Phase I Experimental Therapeutics, stem cell transplantation, and immunotherapies such as CAR T-cell) supported by the latest research. The program provides advanced treatment for children with cancer including brain tumors, leukemia, lymphoma, solid tumors (including Neuroblastoma, Wilms, Liver, Germ Cell, etc.), bone and soft tissue tumors, histiocytic diseases, and vascular tumors.
In 2017, the hospital was recognized as a NCI-designated cancer center consortium partner with the University of Kansas Cancer Center.
“This has been an exciting year for the Children’s Mercy Cancer Center as we added to our National Cancer Institute activity with Children’s Oncology Group the new designation as an NCI-designated cancer center by virtue of our new consortium status with the University of Kansas Cancer Center,” says Alan Gamis, MD, Associate Division Director, Section of Oncology; Professor of Pediatrics, University of Missouri-Kansas City School of Medicine. “Research leading to current and future improvements in cancer care are a cornerstone of this designation.”
Pediatric Oncologists & Specialists
Children’s Mercy is committed to ongoing research to help develop new, more effective treatments for childhood cancer. Because of that commitment, survival rates are frequently above national averages. The care team includes more than 25 pediatric oncologists and hematology specialists. Dedicated nurse practitioners help coordinate each step of treatment. This includes chemotherapy, surgery, radiation, labs, and any other services patients and families need from the time of diagnosis until care is completed. The team creates a care plan suited to each patient’s individual treatment needs.
Cancer Treatment Outcomes in Children
The care team creates a care plan suited to each patient’s individual treatment needs and are driven to continually improve treatment outcomes for pediatric cancers. The charts below reflect survival rates for specific types of cancers treated at Children’s Mercy as well as frequency of diagnosis.
treated at Children’s Mercy as well as frequency of diagnosis.
Advanced Treatment Improves Outcomes for Childhood Cancers